Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | PPARG | P37231 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | POLA1 | P09884 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | PPARA | Q07869 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA7 | P43166 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14947259 | 1.00 | LMNA (0.53) | LMNAL3MBTL1PPARGTSHRDGKA | |
| SCHEMBL13182543 | 0.93 | PPARG (0.48) | LMNAL3MBTL1PPARGTSHRDGKA | |
| SCHEMBL4817776 | 0.92 | FFAR4 (0.57) | PPARGTSHRMAPTPPARAALDH1A1 | |
| SCHEMBL12848526 | 0.90 | POLB (0.47) | LMNAL3MBTL1PPARGTSHRDGKA | |
| SCHEMBL14398806 | 0.89 | FAAH (0.53) | L3MBTL1PPARGPOLBPOLA1EPHX2 | |
| SCHEMBL13850506 | 0.89 | FAAH (0.50) | LMNAL3MBTL1PPARGPOLBPOLA1 | |
| SCHEMBL13359331 | 0.89 | ALDH1A1 (0.50) | LMNAL3MBTL1PPARGTSHRDGKA | |
| SCHEMBL586921 | 0.88 | TSHR (0.67) | LMNATSHRDGKAPOLBPOLA1 | |
| SCHEMBL14687968 | 0.88 | TSHR (0.67) | LMNATSHRDGKAPOLBPOLA1 | |
| SCHEMBL863540 | 0.88 | TSHR (0.67) | LMNATSHRDGKAPOLBPOLA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10669448-B2 | Silane endcapped polyamide resins | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2020-06-02 | — | — | US | disclosed |
| US-20170240704-A1 | SILANE ENDCAPPED POLYAMIDE RESINS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2017-08-24 | — | — | US | disclosed |
| US-9644114-B2 | Silane endcapped polyamide resins | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2017-05-09 | — | — | US | disclosed |
| WO-2016172157-A1 | SILANE ENDCAPPED POLYAMIDE RESINS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2016-10-27 | — | — | WO | disclosed |
| US-20160304746-A1 | SILANE ENDCAPPED POLYAMIDE RESINS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2016-10-20 | — | — | US | disclosed |
| US-9017701-B2 | Organogel compositions comprising alkylated benzimidazolones | XEROX CORPORATION (US) | 2015-04-28 | — | — | US | disclosed |
| US-9017701-B2 | Organogel compositions comprising alkylated benzimidazolones | XEROX CORPORATION (US) | 2015-04-28 | — | — | US | disclosed |
| US-20130123375-A1 | Organogel Compositions Comprising Alkylated Benzimidazolones | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2013-05-16 | — | — | US | disclosed |
| US-20130123375-A1 | Organogel Compositions Comprising Alkylated Benzimidazolones | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2013-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170240704-A1 | SILANE ENDCAPPED POLYAMIDE RESINS | FFAR3, FFAR2, FFAR1 | LMNA 267/4885L3MBTL1 2454/4885PPARG 1294/4885 |
| US-10669448-B2 | Silane endcapped polyamide resins | FFAR3, FFAR2, FFAR1 | LMNA 267/4885L3MBTL1 2454/4885PPARG 1294/4885 |
| US-20130123375-A1 | Organogel Compositions Comprising Alkylated Benzimidazolones | BLM, SBK3, CHEK2 | LMNA 1780/4885L3MBTL1 2956/4885PPARG 991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.